Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
intravenous delivery
Pharma
VacV exits stealth with systemic oncolytic viral delivery tech
VacV Biotherapeutics has taken early steps toward the validation of its systemically deliverable Vaccinia virus, exiting stealth with $3 million.
Nick Paul Taylor
Oct 31, 2022 9:15am
Mitsubishi Tanabe models economic impact of IV-to-oral switch
Aug 2, 2022 7:40am
Ready to prescribe Aduhelm? Docs detail why they will—or won't
Jun 8, 2021 7:40am
Siga seeks FDA approval for intravenous smallpox therapy
May 11, 2021 7:30am
Lilly drives access to COVID antibodies with infusion centers
Feb 1, 2021 10:36am
Alexion's new, quicker-infusing Ultomiris formula snares FDA nod
Oct 16, 2020 12:05pm
